← Open Payments lookup

MIGUEL MACAOAY: Open Payments

NPI 1770673048 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$545 in 26 payments from 9 companies in 2025. Trend: 2023 $430 · 2024 $800 · 2025 $545

Food & beverage: $545
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$133
ABBVIE INC.5$122
Tris Pharma Inc6$94
Vanda Pharmaceuticals Inc.3$74
Corium, LLC2$31
Supernus Pharmaceuticals, Inc.2$29
Teva Pharmaceuticals USA, Inc.1$25
Axsome Therapeutics, Inc.1$21
SANOFI PASTEUR INC.1$17

Products named: INGREZZA, VRAYLAR, Dyanavel XR, HETLIOZ, Onyda XR, Azstarys, Qelbree, AUSTEDO XR.

Industry payments across DC — which companies pay providers there.